Please rate this video

iwCLL 2019 | Assessing the role of CAR-T in CLL

Please rate this video

David Maloney and Johannes Schetelig

David Maloney, MD, PhD, Fred Hutchinson Cancer Center, Seattle, and Johannes Schetelig, MD, WA, University of Dresden, Dresden, Germany, speaking at a roundtable discussion at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK. The speakers elaborate on the future of CAR-T and cellular therapy in chronic lymphocytic leukemia (CLL), particularly as an alternative to allogeneic stem cell transplantation.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter